Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific Meeting

PD-1 is an inhibitory receptor located on conventional T cells, which, when activated, promotes the attenuation of an immune attack.